Hopson： weaker but much better than peers FY22
–Better margin outlook, with Bigo to bottom out
Better Measurement, Better Biopharma Marketing
Building Better Formal Tvet Systems
Better margin improvement ahead
FY22 results below; GPM recovery on better product mix
Better together: Three ways to boost board–CEO collaboration
Kuaishou (1024 HK) Solid 4Q22E with better margin outlook
Better Demand Planning: How Finance Can Lead Its Successful Transformation
China Technology – Semi field trip takeaways： darkness before dawn; fabless better positioned than SPE／materials
公众号
小程序
社群
公众号小程序社群